A case report of heart failure after therapy with ustekinumab
Psoriasis is a chronic immune disorder that affects 2-3% of the US population. Ustekinumab, a monoclonal antibody against IL-23/12, has shown great efficacy in treating psoriasis. Here we present a rare finding of a patient with plaque-type psoriasis who was diagnosed with congestive heart failure a...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2015-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_e526496c79f5432b8bac1c6ce55b1edf | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Kourosh Beroukhim |e author |
| 700 | 1 | 0 | |a Melissa Danesh |e author |
| 700 | 1 | 0 | |a Catherine Nguyen |e author |
| 700 | 1 | 0 | |a John Koo |e author |
| 700 | 1 | 0 | |a Argentina Leon |e author |
| 245 | 0 | 0 | |a A case report of heart failure after therapy with ustekinumab |
| 260 | |b Wolters Kluwer Medknow Publications, |c 2015-07-01T00:00:00Z. | ||
| 500 | |a 2352-2410 | ||
| 500 | |a 10.1016/j.jdds.2015.03.003 | ||
| 520 | |a Psoriasis is a chronic immune disorder that affects 2-3% of the US population. Ustekinumab, a monoclonal antibody against IL-23/12, has shown great efficacy in treating psoriasis. Here we present a rare finding of a patient with plaque-type psoriasis who was diagnosed with congestive heart failure after initiating treatment with ustekinumab. The patient experienced full recovery of cardiac function upon discontinuation of ustekinumab. | ||
| 546 | |a EN | ||
| 690 | |a Psoriasis | ||
| 690 | |a Ustekinumab | ||
| 690 | |a Congestive heart failure | ||
| 690 | |a Adverse drug events | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Dermatology and Dermatologic Surgery, Vol 19, Iss 2, Pp 117-119 (2015) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2352241015000249 | |
| 787 | 0 | |n https://doaj.org/toc/2352-2410 | |
| 856 | 4 | 1 | |u https://doaj.org/article/e526496c79f5432b8bac1c6ce55b1edf |z Connect to this object online. |